Fang X - Search Results

1

Magnetic resonance energy transfer for in vivo glutathione susceptibility weighted imaging.

Wang K, Zhang H, Shen A, Zhao P, Meng X, Chen X, Liu Y, Liu Y, Gong T, Wu W, Fang X, Wang P, Bu W. Wang K, et al. Among authors: fang x. Biomaterials. 2020 Feb;232:119703. doi: 10.1016/j.biomaterials.2019.119703. Epub 2019 Dec 26. Biomaterials. 2020. PMID: 31901504

2

Susceptibility-weighted imaging for metabolic pathway mapping of low-dosage nanoparticles in organisms.

Song C, Meng X, Liu Y, Shen A, Shao C, Wang K, Cheng H, Fang X, Wang P, Bu W. Song C, et al. Among authors: fang x. Biomaterials. 2020 Feb;230:119631. doi: 10.1016/j.biomaterials.2019.119631. Epub 2019 Nov 16. Biomaterials. 2020. PMID: 31761488

3

Negative CT Contrast Agents for the Diagnosis of Malignant Osteosarcoma.

Meng X, Zhang H, Zhang M, Wang B, Liu Y, Wang Y, Fang X, Zhang J, Yao Z, Bu W. Meng X, et al. Among authors: fang x. Adv Sci (Weinh). 2019 Oct 11;6(23):1901214. doi: 10.1002/advs.201901214. eCollection 2019 Dec. Adv Sci (Weinh). 2019. PMID: 31832312 Free PMC article.

4

Cathodic protected Mn²⁺ by Na_xWO₃ nanorods for stable magnetic resonance imaging-guided tumor photothermal therapy.

Liu Y, Wu S, Liu Y, Zhang H, Zhang M, Tang Z, Wang Y, Gong T, Yao Z, Fang X, Bu W. Liu Y, et al. Among authors: fang x. Biomaterials. 2020 Mar;234:119762. doi: 10.1016/j.biomaterials.2020.119762. Epub 2020 Jan 8. Biomaterials. 2020. PMID: 31935593

5

A novel CEST-contrast nanoagent for differentiating the malignant degree in breast cancer.

Chen B, Meng X, Wu W, Zhang Y, Ma L, Chen K, Fang X. Chen B, et al. Among authors: fang x. RSC Adv. 2023 May 9;13(21):14131-14138. doi: 10.1039/d3ra01006f. eCollection 2023 May 9. RSC Adv. 2023. PMID: 37180024 Free PMC article.

6

Fusing Positive and Negative CT Contrast Nanoagent for the Sensitive Detection of Hepatoma.

Meng X, Gao J, Sun Y, Duan F, Chen B, Lv G, Li H, Jiang X, Wu Y, Zhang J, Fang X, Yao Z, Zuo C, Bu W. Meng X, et al. Among authors: fang x. Adv Sci (Weinh). 2023 Dec;10(34):e2304668. doi: 10.1002/advs.202304668. Epub 2023 Oct 23. Adv Sci (Weinh). 2023. PMID: 37870166 Free PMC article.

7

Using biparametric MRI radiomics signature to differentiate between benign and malignant prostate lesions.

Xu M, Fang M, Zou J, Yang S, Yu D, Zhong L, Hu C, Zang Y, Dong D, Tian J, Fang X. Xu M, et al. Among authors: fang x, fang m. Eur J Radiol. 2019 May;114:38-44. doi: 10.1016/j.ejrad.2019.02.032. Epub 2019 Feb 25. Eur J Radiol. 2019. PMID: 31005174

8

Diffusion-weighted MR imaging for detection of extrahepatic cholangiocarcinoma.

Cui XY, Chen HW, Cai S, Bao J, Tang QF, Wu LY, Fang XM. Cui XY, et al. Eur J Radiol. 2012 Nov;81(11):2961-5. doi: 10.1016/j.ejrad.2011.12.040. Epub 2012 Jan 28. Eur J Radiol. 2012. PMID: 22285604

9

Facile Synthesis of Gd-Cu-In-S/ZnS Bimodal Quantum Dots with Optimized Properties for Tumor Targeted Fluorescence/MR In Vivo Imaging.

Yang W, Guo W, Gong X, Zhang B, Wang S, Chen N, Yang W, Tu Y, Fang X, Chang J. Yang W, et al. Among authors: fang x. ACS Appl Mater Interfaces. 2015 Aug 26;7(33):18759-68. doi: 10.1021/acsami.5b05372. Epub 2015 Aug 17. ACS Appl Mater Interfaces. 2015. PMID: 26257133

10

Clinical and Imaging Characteristics of Malignant Tumor Concurrent with Stroke.

Wang F, Hu XY, Cui ZM, Fang XM, Dai Z, Wang T, Guo DL. Wang F, et al. Cancer Biother Radiopharm. 2019 Oct;34(8):504-510. doi: 10.1089/cbr.2019.2853. Epub 2019 Jul 11. Cancer Biother Radiopharm. 2019. PMID: 31295003 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,118 results

Search Page

Filters